AIM
EDIT icon

Aigen Investment Management’s Editas Medicine EDIT Stock Holding History

Aigen Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33,155
Closed -$155K – 802
2024
Q2 		$155K Buy
+33,155
New +$187K 0.03% 655
2024
Q1 		– Sell
-59,209
Closed -$600K – 758
2023
Q4 		$600K Buy
+59,209
New +$520K 0.11% 275
2023
Q3 		– Sell
-11,796
Closed -$97.1K – 895
2023
Q2 		$97.1K Buy
+11,796
New +$103K 0.01% 675
2021
Q3 		– Sell
-3,778
Closed -$214K – 528
2021
Q2 		$214K Sell
3,778
-6,115
-62% -$226K 0.04% 387
2021
Q1 		$416K Buy
+9,893
New +$564K 0.06% 332
2020
Q3 		– Sell
-18,495
Closed -$547K – 915
2020
Q2 		$547K Buy
+18,495
New +$483K 0.07% 432
2020
Q1 		– Sell
-3,262
Closed -$97K – 1330
2019
Q4 		$97K Buy
+3,262
New +$81.5K 0.02% 688

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aigen Investment Management's EDIT Position: Q3 2024 in Review

Aigen Investment Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 33,155 shares — an estimated $155K sold.

Aigen Investment Management first reported a position in EDIT in Q4 2019 and held it in 7 quarters. The position peaked at $600K in Q4 2023. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Aigen Investment Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Aigen Investment Management sold 33,155 Editas Medicine shares in Q3 2024, an estimated $155K.
  • Aigen Investment Management first reported a position in Editas Medicine in Q4 2019 and held it in 7 quarters.
  • Aigen Investment Management's Editas Medicine position peaked at $600K in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.